3 ms·
Ultimately both error rates matter, and are measurable. It's not necessary that these error rates are zero, it's necessary that they are measured, controlled, a
by epistasis 13y ago
Ultimately both error rates matter, and are measurable. It's not necessary that these error rates are zero, it's necessary that they are measured, controlled, and acknowledged, which is what 23andMe is not doing.
Even the FDA isn't arguing that 23andMe should not offer it's service, just that it shouldn't market it. And really, given that they don't seem to be following the basic quality assurance practices of the industry, they should not be marketing at all.
- dragonwriter 13y ago> Even the FDA isn't arguing that 23andMe should not offer it's service, just that it shouldn't market it. They aren't even really arguing that either; they are more arguing that if they are going to market it, then they need to provide studies supporting the accuracy and take other steps to get it approved to be marketed for the particular uses it is being marketed. They are saying in the Warning Letter that 23andMe must stop marketing the product because 23andMe has abandoned the approval process (and apparently was not preventing 23andMe from marketing the product as long as they were working through the approval process), not because the product is inherently unmarketable.